Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Glass House Brands Inc.
SIC 2833 · Medicinal Chemicals & Botanical Products
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Glass House Brands Inc.
SIC 2833 · Medicinal Chemicals & Botanical Products
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Glass House Brands Inc.
SIC 2833 · Medicinal Chemicals & Botanical Products
Notes
Support
about
terms
$
GLAS
Glass House Brands Inc.
CIK:
0001848731
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]
Revenues, Net
$ 181,984
$ 200,898
Cost of Goods Sold (Exclusive of Depreciation and Amortization Shown Separately Below)
105,024
103,505
Gross Profit
76,960
97,393
Operating Expenses:
General and Administrative
64,098
60,126
Sales and Marketing
2,669
2,418
Professional Fees
9,062
7,768
Depreciation and Amortization
15,764
15,044
Impairment Expense for Intangible Assets
1,900
6,300
Total Operating Expenses
93,493
91,656
Income (Loss) from Operations
(16,533)
5,737
Other (Income) Expense:
Interest Expense
7,058
9,184
Interest Income
(288)
0
Gain on Equity Method Investments
(84)
(14)
(Gain) Loss on Change in Fair Value of Derivative Asset and Liability
2,070
(690)
Gain on Change in Fair Value of Contingent Liabilities and Shares Payable
0
(13,724)
Loss on Extinguishment of Debt
292
0
Other (Income) Expense, Net
(8,563)
(238)
Total Other (Income) Expense, Net
485
(5,482)
Income (Loss) from Operations Before Provision for Income Taxes
(17,018)
11,219
Provision for Income Taxes
11,934
10,498
Net Income (Loss)
(28,952)
721
Net Income Attributable to Non-Controlling Interest
707
202
Net Income (Loss) Attributable to the Company
$ (29,659)
$ 519
Loss Per Share - Basic and Diluted
Loss Per Share - Basic (in dollars per share)
$ (0.55)
$ (0.21)
Loss Per Share - Diluted (in dollars per share)
$ (0.55)
$ (0.21)
Weighted-Average Shares Outstanding - Basic and Diluted
Weighted-Average Shares Outstanding - Basic (in shares)
81,935,989
75,229,075
Weighted-Average Shares Outstanding - Diluted (in shares)
81,935,989
75,229,075
v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss)
$ (28,952)
$ 721
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:
Bad Debt Expense, Net of Recoveries
2,557
305
Interest Capitalized
(775)
0
Loss on Disposal of Property and Equipment
1,032
0
Depreciation and Amortization
15,764
15,044
Gain on Equity Method Investments
(84)
(14)
Impairment Expense for Intangible Assets
1,900
6,300
Non-Cash Operating Lease Costs
1,353
1,617
Loss on Extinguishment of Debt
(292)
0
Accretion of Debt Discount and Loan Origination Fees
391
1,690
(Gain) Loss on Change in Fair Value of Derivative Asset and Liability
2,070
(690)
Gain on Change in Fair Value of Contingent Liabilities and Shares Payable
0
(13,724)
Share-Based Compensation
13,402
13,098
Changes in Operating Assets and Liabilities:
Accounts Receivable
(547)
(1,481)
Income Taxes Receivable
1,138
(1,929)
Prepaid Expenses and Other Current Assets
(2,262)
(3,902)
Inventory
(11,975)
(5,412)
Other Assets
3,442
215
Accounts Payable and Accrued Liabilities
5,817
8,413
Interest Payments on Finance Leases
(272)
(258)
Income Taxes Payable
(2,408)
(5,471)
Operating Lease Liabilities
(1,325)
(1,556)
Other Non-Current Liabilities
10,889
15,426
NET CASH PROVIDED BY OPERATING ACTIVITIES
11,447
28,392
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of Property and Equipment
(27,179)
(10,294)
Proceeds from Sale of Assets
222
0
Issuance of Note Receivable
(1,000)
0
Cash Received from Consolidation of Variable Interest Entity
215
0
NET CASH USED IN INVESTING ACTIVITIES
(27,742)
(10,294)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the Issuance of At-the-Money Shares
2,182
0
Proceeds from the Issuance of Notes Payable, Third Parties and Related Parties
52,099
0
Proceeds from the Issuance of Preferred Shares
18,492
0
Redemption of Preferred Shares
(18,498)
0
Payment on Finance Lease
(1,013)
(478)
Payments on Notes Payable, Third Parties and Related Parties
(42,893)
(7,557)
Cash Received Upon Exercise of Options and Warrants
1,000
2,194
Distributions to Non-Controlling Interest Holders
(342)
(109)
Distributions to Preferred Shareholders
(8,305)
(7,749)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES
2,722
(13,699)
NET INCREASE (DECREASE) IN CASH, RESTRICTED CASH AND CASH EQUIVALENTS
(13,573)
4,399
Cash, Restricted Cash and Cash Equivalents, Beginning of Period
36,923
32,524
CASH, RESTRICTED CASH AND CASH EQUIVALENTS, END OF PERIOD
23,350
36,923
SUPPLEMENTAL DISCLOSURE FOR CASH FLOW INFORMATION
Cash Paid for Interest
4,527
5,992
Cash Paid for Taxes
2,458
2,457
Non-Cash Investing and Financing Activities:
Exchange of Series B and Series C Preferred Shares for Series E Preferred Shares
59,008
0
Reclassification of Preferred Shares from Non-Controlling Interest to Additional Paid-In Capital
52,323
0
Contingent Shares Payable in Connection with Camarillo Acquisition
20,265
0
Variable Interest Entity Consolidation
12,865
0
Issuance of At-the-Money shares
3,946
66
Shares Issued to Settle Shares Payable - NHC Business Acquisitions
2,579
3,834
Shares Issued for Payment of Interest on Convertible Debentures
1,292
1,292
Shares Issued for 2024 and 2023 Bonus, respectively
1,114
2,715
Interest Capitalized to Property and Equipment
775
0
Shares Issued to Acquire Remaining Non-Controlling Interest in Consolidated Subsidiary
600
0
Recognition of Right-of-Use Asset and Lease Liability for Finance Lease
403
1,293
Shares Issued for Vested GH Group Non-Qualified Options
0
2,757
Lease Terminations and Amendments
$ 0
$ 22
v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current Assets:
Cash
$ 19,850
$ 33,923
Restricted Cash
0
3,000
Accounts Receivable, Net
4,417
5,221
Income Taxes Receivable
791
1,929
Prepaid Expenses and Other Current Assets
15,664
7,775
Inventory
26,227
14,252
Notes Receivable
800
0
Total Current Assets
67,749
66,100
Operating Lease Right-of-Use Assets, Net
3,875
8,168
Finance Lease Right-of-Use Assets, Net
2,036
2,568
Long Term Investments
0
2,341
Property, Plant and Equipment, Net
228,760
212,252
Intangible Assets, Net
11,577
14,200
Restricted Cash, Net of Current Portion
3,500
0
Other Assets
1,060
4,873
TOTAL ASSETS
318,557
310,502
Current Liabilities:
Accounts Payable and Accrued Liabilities
35,970
31,128
Income Taxes Payable
0
2,408
Contingent Shares Payable and Earnout Liabilities
0
20,265
Shares Payable
0
2,579
Current Portion of Operating Lease Liabilities
1,116
1,565
Current Portion of Finance Lease Liabilities
836
889
Current Portion of Notes Payable
37
7,644
Total Current Liabilities
37,959
66,478
Operating Lease Liabilities, Net of Current Portion
2,868
6,860
Finance Lease Liabilities, Net of Current Portion
1,086
1,688
Other Non-Current Liabilities
33,413
20,869
Notes Payable, Net of Current Portion
68,629
50,552
TOTAL LIABILITIES
143,955
146,447
SHAREHOLDERS’ EQUITY:
Additional Paid-In Capital
294,011
306,652
Accumulated Deficit
(220,075)
(190,416)
Total Shareholders’ Equity Attributable to the Company
73,936
116,236
Non-Controlling Interest
8,166
(38,544)
TOTAL MEZZANINE EQUITY AND SHAREHOLDERS' EQUITY
174,602
164,055
TOTAL LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY
318,557
310,502
Preferred Series B Shares
MEZZANINE EQUITY:
Preferred shares, value
0
65,084
Preferred Series C Shares
MEZZANINE EQUITY:
Preferred shares, value
0
6,279
Preferred Series D Shares
MEZZANINE EQUITY:
Preferred shares, value
15,000
15,000
Series E Convertible Preferred Shares
MEZZANINE EQUITY:
Preferred shares, value
77,500
0
Multiple Voting Shares
SHAREHOLDERS’ EQUITY:
Common shares, value
0
0
Subordinate Voting Shares
SHAREHOLDERS’ EQUITY:
Common shares, value
0
0
Exchangeable Shares
SHAREHOLDERS’ EQUITY:
Common shares, value
$ 0
$ 0